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Techniques commonly employed in the field of cognitive neurosci-
ence (described here as neuroscience techniques) are increasingly 
being used to investigate the likely impact of tobacco control meas-
ures. The overarching premise of our narrative review is that these 
techniques can complement and extend self-report and behavioral 
research approaches commonly used to evaluate tobacco control 
measures. First, we describe how neuroscience techniques can over-
come some of the limitations of these other research techniques. 
Second, we provide a review of studies using eye tracking, electroen-
cephalography (EEG), and functional magnetic resonance imaging 
(fMRI; see Box 1 for a more detailed description of these techniques) 
to evaluate these policies, with a particular focus on standardized 
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Abstract
Introduction: Techniques employed in the field of neuroscience, such as eye tracking, elec-
troencephalography, and functional magnetic resonance imaging, have been important in 
informing our understanding of the cognitive mechanisms underlying tobacco smoking. These 
techniques are now increasingly being used to investigate the likely impact of tobacco control 
policies.
Aims and Methods: In this narrative review, we outline the value of these methodological 
approaches in answering policy-relevant tobacco control research questions, with a particular 
focus on their use in examining the impact of standardized cigarette packaging and health warn-
ings. We also examine the limitations of these methodologies and provide examples of how they 
can be used to answer other policy-relevant questions.
Results: We argue that neuroscience techniques can provide more objective evidence of the 
impacts of policy measures, allow investigation where it is not possible to conduct behavioral 
manipulations, and facilitate a deeper understanding of the cognitive mechanisms underlying the 
impacts of tobacco control policies such as standardized packaging, health warnings, point-of-sale 
displays, and mass media campaigns.
Conclusions: Rather than replacing more traditional methods of examining tobacco control meas-
ures, such as observational experiments, surveys, and questionnaires, neuroscience techniques 
can complement and extend these methods.
Implications: Neuroscience techniques facilitate objective examination of the mechanisms under-
lying the impacts of tobacco control measures. These techniques can therefore complement and 
extend other methodologies typically used in this field, such as observational experiments, sur-
veys, and questionnaires.
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packaging and health warnings. Third, we discuss the limitations 
of these techniques. We conclude with a discussion of the future of 
neuroscience techniques for tobacco control research and provide a 
framework for future research.
Overcoming the Limitations of Other 
Methodologies
Every research methodology has its limitations (and we discuss 
limitations with neuroscience techniques later). However, techniques 
used in neuroscience can overcome some of the limitations associ-
ated with methodologies often used to examine questions related 
to tobacco control policies, including those relying on subjective 
responses.
Providing More Objective Measures
Traditionally, research examining the potential effectiveness of 
tobacco control measures has relied on subjective response method-
ologies, such as surveys, focus groups, and questionnaires. A recent 
systematic review of 68 experimental studies comparing text-only 
warnings with pictorial health warnings identified a total of 278 
outcome measures characterizing 61 constructs across these stud-
ies.1 Of these, only 23 outcomes were objective (visual attention 
n = 10, recall/recognition n = 5, response time n = 3, quitline calls 
n = 1, and smoking behavior n = 4). Despite considerable converg-
ing evidence,2,3 tobacco industry advocates argue that approaches 
relying on subjective reports do not constitute “credible evidence.”4  
Tobacco industry criticisms on the grounds of a lack of credible evi-
dence are likely to have slowed United Kingdom government deci-
sion-making on standardized packaging5,6 and US decision-making on 
health warnings.7 Indeed, as intentions are known to only play a small 
role in actual behavior,8 research which relies on self-reported out-
comes has also been criticized by academics within the field of tobacco 
control who have argued that experimental designs with reliable, 
behavioral measures are required to provide “convincing evidence.”9 
Neuroscience techniques allow us to examine processes and behav-
iors that are outside of the awareness of individuals and therefore 
are not subject to these same criticisms.
Facilitating Investigation Where Behavioral 
Manipulations Are Not Possible
Behavioral research methodologies can indeed provide more con-
vincing evidence of the effects of a proposed tobacco control meas-
ure. A recent randomized controlled trial evaluated the effects of 
pictorial cigarette pack warnings on quit attempts,10 while another 
has examined the impact of standardized packaging on actual 
smoking behavior.11 Similarly, in a recently completed randomized 
controlled trial, the effects of reducing the nicotine content in ciga-
rettes on smoking behavior over 6 weeks were evaluated in a diverse 
sample of US smokers.12 The results provide more compelling evi-
dence than would a survey study asking smokers to self-report on 
their opinions or imagined reactions to a reduced-nicotine ciga-
rette. However, while studies with behavioral outcomes provide a 
more rigorous evaluation of potential policy measures than those 
relying on subjective reports, these evaluations can take years to 
complete and require large sample sizes and long follow-up periods 
in order to observe the downstream effects of these interventions.13
In addition, behavioral outcomes are not possible when the 
policy manipulation is outside the control of the experimenter. 
For example, it is typically not feasible to randomly assign half 
of a country to a tobacco control measure such as standardized 
packaging and compare its effects on smoking outcomes to the 
half of the population continuing with normal practice. Instead, 
policymakers will wait for evidence from other countries that 
have introduced a tobacco control measure before implement-
ing it themselves. For example, the United Kingdom, Ireland, 
and France waited for pre/postevaluations of the effectiveness of 
standardized packaging in Australia14–16 before implementing it. 
However, this is not always feasible, and generalizing from one 
country to another is an important limitation of this kind of eval-
uation. Neuroscience techniques can provide objective evidence 
of the likely effects of a tobacco control measure but in a consid-
erably shorter timescale.
Allowing a Deeper Analysis of Cognitive Mechanism
Studies with behavioral outcomes, while providing evidence 
regarding the impact of policy on target endpoints, are also lim-
ited in their ability to explain why a policy intervention worked 
in the manner it did. Neuroscience techniques have been impor-
tant in informing our understanding of the cognitive mechanisms 
underlying tobacco smoking, including nicotine withdrawal,17,18 
the impact of quitting smoking,19 prediction of cessation out-
comes,20–23 and cue reactivity.24–26 These techniques are increas-
ingly being used to examine the cognitive mechanisms underlying 
responses to tobacco control measures. In some cases, insights 
into cognitive mechanism may be obvious (eg, nicotine is the pri-
mary psychoactive component of tobacco smoke, and reducing 
it to negligible levels decreases smoking reinforcement) or unim-
portant. However, in other cases, a deeper understanding of how 
a policy manipulation exerts its influence can result in insights 
necessary for further refinement and even greater impact. For 
example, understanding why a particular health warning is effec-
tive at encouraging thoughts about quitting can inform develop-
ment of future health warnings. Furthermore, while a group of 
participants in a study may all exhibit the same self-reported or 
behavioral response to one stimulus or manipulation, the underly-
ing cognitive and neural processes by which they arrive at those 
outcomes may vary in meaningful ways.
The Use of Neuroscience Techniques in Tobacco 
Control Research
By measuring processes and behaviors that are outside of the 
awareness of individuals, neuroscience techniques can overcome 
many of the limitations of methodologies relying on both subjec-
tive and behavioral responses. These techniques include eye track-
ing, EEG, and fMRI and are commonly used in market research to 
understand how neuroscience can inform consumer decision-mak-
ing and increase purchasing behavior.27–29 Box 1 describes these 
techniques in more detail, and in the following sections, we pro-
vide a review of studies using these techniques to answer tobacco 
policy-relevant questions, with the goal of ultimately reducing 
purchasing of tobacco by reducing smoking initiation and encour-
aging cessation.
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Eye Tracking
Eye tracking has been used for decades by consumer marketers, from 
studies examining visual attention to adverts in the Yellow Pages30 
to those exploring the cognitive mechanisms underlying supermar-
ket choices.31 This methodology provides an objective measure of 
what visual stimuli or objects individuals are attending to, and which 
aspects of the environment capture attention. The value of this 
research technique is also recognized by the tobacco industry, who 
have used mobile eye tracking (see Box 1) to examine the impact of 
tobacco point-of-sale displays on visual attention.32 Similar research 
has been conducted by academics.33
One of the mechanisms through which standardized packag-
ing is expected to be effective is by increasing the salience of health 
warnings.2,3 Research using eye-tracking technology has therefore 
been particularly valuable in objectively measuring visual attention 
to health warnings on branded and standardized packaging,34–38 
observing that standardized packaging increases visual attention 
to warnings among adult and adolescent nonsmokers and nondaily 
smokers.34,35,37 Other research has found that this is observed for 
text-only warnings and pictorial health warnings on standardized 
packs.38 Eye-tracking research was cited in the legal case between 
British American Tobacco and the UK Department of Health regard-
ing the legality of standardized packaging legislation39 and was 
described as using “objective physiological techniques.” This research 
adds weight to and extends findings obtained using other research 
methodologies, including focus groups,40,41 quantitative surveys,42,43 
and naturalistic studies,44,45 which have reported similar effects.
By measuring which components of a health warning smokers 
are attending to and consequently which are impacting their self-
reported reactions, eye-tracking technology allows greater under-
standing of the cognitive mechanisms underlying the influence of 
tobacco marketing materials on self-reported reactions and behav-
ioral effects (see Figure 1a and b and Box 1 that demonstrate how 
eye tracking can be used to examine attention to discrete regions of a 
cigarette pack advertisement). This is particularly important, as eye-
tracking research suggests that daily smokers avoid currently used 
warnings,36 indicating that different strategies for capturing attention 
are required among this population. Studies using this technique have 
examined the impact of varying a number of different health warning 
components including novelty,46,47 size,48 format,49,50 and emotional 
content51 on visual attention. Other research has used eye tracking to 
examine the impact of risk statements,52 message congruency,53 and 
pictorial warnings49 in cigarette advertisements on visual attention.
Box 1. Neuroscience Techniques Explained
Eye tracking
Attention to a stimulus is recognized as an important prerequi-
site for behavior change.54 While early eye trackers were inva-
sive and relied on direct and invasive observations of the eye,80 
today’s eye trackers typically measure eye movements using 
noninvasive optical tracking with a video-based eye tracker. 
At the most basic level, eye movements can be divided into 
fixations (when the eye is stable in a particular location) and 
saccades (when it is moving to another location). Researchers 
typically examine the location of the first fixation, the dura-
tion of fixations, or the number of fixations. These measures 
provide an indication of visual attention toward a stimulus 
(ie, a tobacco health warning). Eye trackers are either “static” 
or “mobile.” When using a static eye tracker, the participant 
is static and views 2D stimuli on screen (either still or mov-
ing images). By contrast, using a mobile eye tracker allows 
for analysis of eye movements when individuals are mobile in 
naturalistic or real-world environments.
Eye tracking can be used to answer questions such as 
“Which elements of pro/anti-tobacco messages capture atten-
tion?” “How is attention allocated in tobacco retail environ-
ments?” “How does attention to vaping cues influence later 
smoking behavior?”
Electroencephalography
During EEG, electrodes are placed over the skull to measure 
changes in the electric field being produced by the brain. Event-
related potentials (ERPs), which reflect the specific electrical 
activity related to a specific sensory “event” (ie, seeing an image 
on a computer screen), can be measured using EEG. ERPs 
can refer to different components, such as P300, where each 
component is typically quantified by its amplitude and latency 
related to the onset of the sensory event. Although EEG has 
poor spatial resolution (ie, it is difficult to determine exactly 
where in the brain the electrical activity is coming from), EEG 
affords excellent temporal resolution (within the millisecond 
range), meaning that it is useful for measuring brain activity 
over time. A large volume of literature has previously used EEG 
to explore the mechanisms underlying tobacco addiction and 
the P300 ERP, which is related to attentional processes, and 
participant arousal state81 has been reliably shown to reflect the 
heightened incentive value of smoking cues among smokers.82
EEG can be used to answer questions such as “Do 
anti-tobacco advertisements successfully elicit emotional 
responses?” “What are the neural indices underlying smokers’ 
reactance to health warnings?” “What is the minimum nicotine 
content needed to induce change in neural activity?”
Functional magnetic resonance imaging
The basic principle behind functional magnetic resonance 
imaging (fMRI) is that when a region of the brain is more 
active, it uses more oxygen, resulting in an increased blood flow 
to this region. fMRI works by detecting these changes in blood 
oxygenation and flow and measures blood oxygenation–level 
dependent (BOLD) signal in the brain. Unlike EEG, fMRI 
has relatively poor temporal resolution (~1  s) because of the 
slower speed of blood when compared with electrical impulses. 
However, the spatial resolution of fMRI (approximately 
1–2 mm) is much greater than EEG, meaning that fMRI can be 
used to create maps that show the activated regions of the brain 
during certain tasks. fMRI is therefore important in under-
standing the neural mechanisms underlying behavior change.
fMRI can be used to answer questions such as “How do 
tobacco advertisements influence neural responses to reward?” 
“What effect does vaping during scanning have on neural 
responses related to reward and craving?” “How do neural 
responses to anti-tobacco messages predict later choice of 
tobacco products above and beyond self-report?”
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Electroencephalography
Despite considerable research showing that pictorial warnings are 
more effective than text-only warnings,10,54 the literature on which 
types of pictorial warnings are more effective and the psychological 
processes underlying responses to them is less well understood. For 
example, a number of self-report studies have found that pictorial 
warnings evoke both positive (ie, increased warning credibility and 
cognitive elaboration) and negative responses (ie, negative affect-
ive reactions and psychological reactance).54 By examining correla-
tions between self-reported reactions and brain activation, EEG and 
specifically examination of particular event-related potentials (see Box 1) 
have allowed us to begin to understand the cognitive mechanisms 
underlying these self-reported responses.
Stothart et  al.55 used EEG to understand the cognitive mecha-
nism underlying avoidance of health warnings among smokers, a 
finding previously observed using both self-report56 and eye-track-
ing36 research. While smokers showed no differences in early per-
ceptual processing when compared with nonsmokers (as indexed by 
the P1, P300, and visual mismatch negativity event-related poten-
tials), they showed reduced later cognitive responses to the warnings 
Figure 1. (a) Typical desk-mounted eye tracker setup (image from Flickr—https://flic.kr/p/7YWwiE); (b) eye-tracking data from a single participant showing the 
focus of visual attention when viewing two different cigarette packs (cigarette packs photographed by OMM and branding information blanked out). Unpublished 
data taken with permission from OMM; (c) typical EEG setup (image with permission from the School of Experimental Psychology, University of Bristol); (d) 
difference waveforms (ie, responses to health warnings subtracted from responses to control stimuli) illustrating greater emotional response (as measured 
using the late positive potential) to warnings for nonsmokers versus daily smokers. Data taken with permission from Stothart et al.55; (e) typical fMRI setup 
(image with permission from the School of Experimental Psychology, University of Bristol); and (f) brain activation associated with processing of high emotional 
reaction (ER) compared with low ER warnings. Data taken with permission from Wang et al.62
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(as indexed by reduced late positive potential, an event-related 
potential which is modulated by stimulus emotional intensity) when 
compared with nonsmokers. This suggests that smokers’ avoidance 
of health warnings is not due to differences in perceptual processing 
of the health warnings, but rather due to reduced sensitivity to the 
emotional content of health warnings (see Figure 1d).
In a similar EEG study, Wang et al.57 found that presentation of 
health warnings rated high on a scale of emotional reaction prior to 
the presentation of a smoking-related cue reduced the subsequent 
P300 amplitude when compared with those warnings rated lower 
on the emotional reaction scale (see Box 1 for a description of the 
P300 event-related potential). Similarly, a recent study by Cochran 
et  al. observed that disgust-based health warnings, but not health 
anxiety-based warnings, reduced attentional processing of smoking 
cues (as indexed using EEG).58 Together, these studies indicate that 
although smokers may avoid health warnings, graphic warnings that 
evoke a strong emotional reaction (such as those proposed for use 
in the United States) may be effective at changing relevant behaviors 
(ie, cue reactivity), thus providing new insights into the cognitive 
mechanisms underlying the effects of health warnings.
Functional Magnetic Resonance Imaging
Two previous studies have used fMRI to examine the impact of 
standardized cigarette packaging on neural activation. While one 
study observed no differences in neural activation for branded when 
compared with standardized packs among daily smokers,59 another 
which combined fMRI with eye tracking observed that when taking 
visual attention to health warnings into account, standardized when 
compared with branded packaging increased activation in the visual 
cortex, suggesting that standardized packaging increases the visual 
salience of health warnings.60 fMRI has also been used to examine 
neural activity when smokers are presented with cigarette package 
health warnings and have found that pictorial warnings activate 
large-scale neural networks including the hippocampus, fusiform 
gyrus, and supplementary motor area61 and the amygdala, medial 
prefrontal cortex, medial temporal lobe, and occipital cortex59 (see 
Figure 1f). In another fMRI study, warnings rated as being of higher 
emotional salience resulted in increased activation in the amygdala, 
hippocampus, and inferior frontal gyrus when compared with those 
rated as being of lower emotional salience.62 Together, these fMRI 
studies support research using qualitative and observational tech-
niques and demonstrate the potential impact of standardized pack-
aging and tobacco health warnings on behavior and the processes 
underlying these behavioral effects.
Future research in this field can draw on well-validated neu-
ral indices (ie, those related to valuation of products) to provide 
an objective assessment of the effects of product features such as 
health warnings on behavior (ie, the actual value assigned to that 
product). The ventromedial prefrontal cortex, for instance, has 
been shown to index the valuation of products across multiple dif-
ferent attributes of goods.63 In a study by Knutson et al.,64 brain 
activation in insula, ventral striatum, and medial prefrontal cor-
tex during the evaluation of a product predicted later choice to 
purchase the product above and beyond self-reported preference 
for the product. Similar studies, but with tobacco products, could 
evaluate the influence of product attributes (eg, warning labels, 
standardized packaging) on product valuation, as well as allow for 
the comparison of valuation across product categories (eg, e-cig-
arettes vs. conventional cigarettes). The potential of this mixed 
methodological approach in the field of tobacco control has been 
demonstrated by Falk et al. who found that the extent to which ant-
ismoking messages activated the medial prefrontal cortex predicted 
the success of those same antismoking messages at the population 
level.65 Combining neural data with self-reported responses to the 
campaign accounted for the largest proportion of the variation in 
the population-level success of the campaign, demonstrating the 
added value of the neural predictor.65 Similarly, activation in the 
medial prefrontal cortex has been shown to be predictive of suc-
cessful smoking cessation (as measured using expired carbon mon-
oxide) over and above self-reported intentions to quit, self-efficacy, 
and the ability to relate to health messages.66 This technique could 
therefore be used to augment self-report measures which are typi-
cally used as predictors of behavior and may be particularly useful 
when self-reported preferences and actual behavior are likely to 
diverge (ie, due to social desirability bias).
Limitations of Neuroscience Techniques and 
Possibilities for the Future
Although these neuroscience research techniques can be valuable 
adjuncts to other experimental and qualitative research and can 
provide important insights into the potential cognitive mechanisms 
underlying the effectiveness of tobacco control measures, they also 
have some important limitations.
Ecological Validity
While these techniques afford excellent internal validity, allowing 
researchers to manipulate different elements of the tobacco control 
measure (ie, the type of health warning or the color of the “standard-
ized” packaging), their ecological validity is limited. However, these 
limitations are not insurmountable. Indeed, there is a long history 
of using these techniques in market research to answer questions 
related to consumer behavior.27–29
Purchasing behavior can be modeled during fMRI by giving sub-
jects a set amount of money that can be allocated across purchasing 
decisions with later, real-world delivery of those products.64 Recently, 
researchers have conducted the first feasibility trial demonstrating 
the use of an e-cigarette during fMRI scanning.67 Furthermore, with 
improvements in technology, neuroscience techniques are increas-
ingly being taken into real-world environments. For example, mobile 
EEG68 and eye tracking33,69 equipment allow us the possibility of 
examining neural responses and visual attention in the real world, 
such that the impact of real, 3D cigarette packs on visual attention 
to health warnings can be assessed. In addition, a growing num-
ber of studies are bringing real-world, personally relevant stimuli 
into the lab and scanning environment for assessment of subjec-
tive and neural reactivity70,71; in the future, such methods could be 
applied to the study of real-world tobacco retail and point-of-sale 
environments. Furthermore, recent advances in virtual reality (VR) 
technology mean that some of the limitations of these neuroscience 
techniques can be overcome even in controlled laboratory settings. 
Using VR headsets, participants can be immersed in life-like scenes 
in combination with neuroscience techniques. This technology has 
been used to investigate the impact of smoking cues in VR environ-
ments on craving,72 and as a result, the impact of VR smoking cue 
exposure therapy on smoking cessation success.73 Moreover, at least 
three studies have evaluated craving and tobacco product purchas-
ing behaviors in virtual tobacco retail outlets74–76 As far as we are 
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aware, however, VR has yet to be combined with simultaneous eye 
tracking, EEG, or fMRI, or other neuroscience techniques, to answer 
questions relevant to tobacco control.
Generalizability
In addition to relatively poor ecological validity, the degree to which 
findings from neuroscience research are generalizable is also a poten-
tial limitation. Indeed, it is important to determine to what extent the 
behaviors observed using neuroscience techniques are predictive of 
actual behavioral responses to tobacco control measures. For exam-
ple, the extent to which visual attention to health warnings34–38 or 
neural responses to standardized packaging59 replicate that observed 
when a smoker pulls a cigarette pack from their pocket is unknown. 
Studies that use a combination of methodological approaches can 
attempt to bridge this gap. Neuroscience measures should be used 
in combination with questionnaires or biological measures (such as 
cotinine) to understand the relationship between the neuroscience 
measure and actual behavior. As described in the fMRI subsection, 
neural measures are increasingly being used to improve predictions 
of decision-making models, where neural activation predecision can 
predict later choice.64
Other Considerations
Finally, each of the neuroscience techniques described here has 
several inherent limitations that researchers interested in their use 
should consider. These include high set-up costs and large amounts 
of time and skill required to run experiments and analyze the data. 
This technical obstacle can be overcome by forming collaborations 
between researchers with different research backgrounds. For a 
more detailed description of the techniques that have been described 
here, including their advantages and disadvantages, readers should 
refer to the review by Kable,77 which also outlines other techniques 
that have not been mentioned here, including magnetoencephalog-
raphy, positron emission tomography, near-infrared spectroscopy, 
transcranial magnetic stimulation, and transcranial direct current 
stimulation.
Conclusions
This review has focused on the role of neuroscience techniques in 
addressing research questions related to tobacco control policies, in 
particular, standardized packaging and health warnings. Other possi-
bilities for future research are also discussed in Box 1. Indeed, the scope 
of these research techniques goes far beyond what we have described 
here, and our review should therefore be seen as a springboard for 
future research. For instance, these techniques can be used to examine 
other tobacco product marketing practices including point-of-sale dis-
plays, tobacco advertisements, and mass media campaigns. Similarly, 
neuroscience techniques can be applied to evaluate novel strategies 
for restricting, modifying, or banning tobacco advertisements or to 
study the effects of modified tobacco products and determine their 
likely impact. Beyond tobacco control, these techniques can answer 
policy-relevant research questions in other fields, such as the potential 
impacts of alcohol advertisements78 and food labeling.79
Rather than replacing more traditional methods of examining 
tobacco control measures, such as observational experiments, sur-
veys, and questionnaires, neuroscience techniques should be a useful 
adjunct to these methods. These techniques can provide more objec-
tive evidence of the impacts of policy measures, allow investigation 
where it is not possible to conduct behavioral manipulations, and 
facilitate a deeper understanding of the cognitive mechanisms under-
lying the impacts of tobacco control policies. In addition, it seems 
that results from neuroscience studies can be more persuasive legally 
than those relying on more subjective methodologies. Although our 
research questions should not be solely led by their potential to have 
“impact,” this is an important consideration when working in a field 
with such clear implications for policy. We hope our review demon-
strates that we can use the techniques developed in the consumer neu-
roscience literature that focus on the goal of increasing purchasing 
behavior and turn these on their heads to reduce tobacco purchasing.
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